Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib

Herbal products are widely used in cancer patients via co−administration with chemotherapy. Previous studies have demonstrated that pharmacokinetic interactions between herbs and anticancer drugs exist due to inhibition of drug−metabolizing enzymes, particularly cytochrome P450s (CYPs). The aim of t...

Full description

Bibliographic Details
Main Authors: Chumaphorn Rodseeda, Paveena Yamanont, Darawan Pinthong, Porntipa Korprasertthaworn
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750022002001
_version_ 1811178684201041920
author Chumaphorn Rodseeda
Paveena Yamanont
Darawan Pinthong
Porntipa Korprasertthaworn
author_facet Chumaphorn Rodseeda
Paveena Yamanont
Darawan Pinthong
Porntipa Korprasertthaworn
author_sort Chumaphorn Rodseeda
collection DOAJ
description Herbal products are widely used in cancer patients via co−administration with chemotherapy. Previous studies have demonstrated that pharmacokinetic interactions between herbs and anticancer drugs exist due to inhibition of drug−metabolizing enzymes, particularly cytochrome P450s (CYPs). The aim of this study was to determine the inhibitory effects of Andrographis paniculata, Curcuma zedoaria, Ganoderma lucidum, Murdannia loriformis and Ventilago denticulata extracts on the metabolism of gefitinib, lapatinib and sorafenib. The activities of CYP3A in human liver microsome on the metabolism of gefitinib, lapatinib and sorafenib in the absence and presence of Thai herbal extracts were assayed using high-performance liquid chromatography analysis. Curcuma zedoaria extract potently inhibited CYP3A−mediated lapatinib and sorafenib metabolism with IC50 values of 4.18 ± 3.20 and 7.59 ± 1.23 μg/mL, respectively, while the metabolism of gefitinib was strongly inhibited by Murdannia loriformis and Ventilago denticulata extracts with IC50 values of 7.53 ± 2.87 and 7.06 ± 1.23 μg/mL, respectively. Andrographis paniculata and Ganoderma lucidum extracts had less effect on the metabolism of the tested anticancers (IC50 values >10 μg/mL). In addition, kinetic analysis of the ability of Curcuma zedoaria extract to inhibit CYP3A-mediated metabolism of anticancer drugs was best described by the noncompetitive and competitive inhibition models with Ki values of 20.08 and 11.55 μg/mL for the metabolism of gefitinib and sorafenib, respectively. The present study demonstrated that there were potential pharmacokinetic interactions between tyrosine kinase inhibitors and herbal extracts.
first_indexed 2024-04-11T06:22:29Z
format Article
id doaj.art-fac47667ba22412b90045a110713435e
institution Directory Open Access Journal
issn 2214-7500
language English
last_indexed 2024-04-11T06:22:29Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj.art-fac47667ba22412b90045a110713435e2022-12-22T04:40:32ZengElsevierToxicology Reports2214-75002022-01-01918461852Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenibChumaphorn Rodseeda0Paveena Yamanont1Darawan Pinthong2Porntipa Korprasertthaworn3Graduate Program in Toxicology, Faculty of Science, Mahidol University, Bangkok, Thailand; Department of Occupational Health and Safety, School of Public Health, University of Phayao, Phayao, Thailand; Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, ThailandDepartment of Pharmacology, Faculty of Science, Mahidol University, Bangkok, ThailandDepartment of Pharmacology, Faculty of Science, Mahidol University, Bangkok, ThailandGraduate Program in Toxicology, Faculty of Science, Mahidol University, Bangkok, Thailand; Center of Excellence on Environmental Health and Toxicology (EHT), OPS, MHESI, Thailand; Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand; Correspondence to: Department of Pharmacology, Faculty of Science, Mahidol University, 272 Rama VI Road, Ratchathewi, Bangkok 10400, Thailand.Herbal products are widely used in cancer patients via co−administration with chemotherapy. Previous studies have demonstrated that pharmacokinetic interactions between herbs and anticancer drugs exist due to inhibition of drug−metabolizing enzymes, particularly cytochrome P450s (CYPs). The aim of this study was to determine the inhibitory effects of Andrographis paniculata, Curcuma zedoaria, Ganoderma lucidum, Murdannia loriformis and Ventilago denticulata extracts on the metabolism of gefitinib, lapatinib and sorafenib. The activities of CYP3A in human liver microsome on the metabolism of gefitinib, lapatinib and sorafenib in the absence and presence of Thai herbal extracts were assayed using high-performance liquid chromatography analysis. Curcuma zedoaria extract potently inhibited CYP3A−mediated lapatinib and sorafenib metabolism with IC50 values of 4.18 ± 3.20 and 7.59 ± 1.23 μg/mL, respectively, while the metabolism of gefitinib was strongly inhibited by Murdannia loriformis and Ventilago denticulata extracts with IC50 values of 7.53 ± 2.87 and 7.06 ± 1.23 μg/mL, respectively. Andrographis paniculata and Ganoderma lucidum extracts had less effect on the metabolism of the tested anticancers (IC50 values >10 μg/mL). In addition, kinetic analysis of the ability of Curcuma zedoaria extract to inhibit CYP3A-mediated metabolism of anticancer drugs was best described by the noncompetitive and competitive inhibition models with Ki values of 20.08 and 11.55 μg/mL for the metabolism of gefitinib and sorafenib, respectively. The present study demonstrated that there were potential pharmacokinetic interactions between tyrosine kinase inhibitors and herbal extracts.http://www.sciencedirect.com/science/article/pii/S2214750022002001Herbal extractTyrosine kinase inhibitorCytochrome P450 3ADrug−herb interaction
spellingShingle Chumaphorn Rodseeda
Paveena Yamanont
Darawan Pinthong
Porntipa Korprasertthaworn
Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib
Toxicology Reports
Herbal extract
Tyrosine kinase inhibitor
Cytochrome P450 3A
Drug−herb interaction
title Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib
title_full Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib
title_fullStr Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib
title_full_unstemmed Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib
title_short Inhibitory effects of Thai herbal extracts on the cytochrome P450 3A-mediated the metabolism of gefitinib, lapatinib and sorafenib
title_sort inhibitory effects of thai herbal extracts on the cytochrome p450 3a mediated the metabolism of gefitinib lapatinib and sorafenib
topic Herbal extract
Tyrosine kinase inhibitor
Cytochrome P450 3A
Drug−herb interaction
url http://www.sciencedirect.com/science/article/pii/S2214750022002001
work_keys_str_mv AT chumaphornrodseeda inhibitoryeffectsofthaiherbalextractsonthecytochromep4503amediatedthemetabolismofgefitiniblapatinibandsorafenib
AT paveenayamanont inhibitoryeffectsofthaiherbalextractsonthecytochromep4503amediatedthemetabolismofgefitiniblapatinibandsorafenib
AT darawanpinthong inhibitoryeffectsofthaiherbalextractsonthecytochromep4503amediatedthemetabolismofgefitiniblapatinibandsorafenib
AT porntipakorprasertthaworn inhibitoryeffectsofthaiherbalextractsonthecytochromep4503amediatedthemetabolismofgefitiniblapatinibandsorafenib